Literature DB >> 9143341

Engineered porcine pepsinogen exhibits dominant unimolecular activation.

T Tanaka1, R Y Yada.   

Abstract

An engineered pepsinogen, which was a fusion protein of thioredoxin and pepsinogen, exhibited dominant self-activation (unimolecular reaction; intramolecular activation) in contrast to recombinant pepsinogen which exhibited both unimolecular and bimolecular reactions (intermolecular activation mediated by pepsin released during activation). At pH values of 1.1, 2.0, and 3.0, activation curves for the engineered pepsinogen were hyperbolic rather than sigmoidal, indicating that self-activation was the dominant activation mechanism in comparison to the slower bimolecular activation. To confirm which activation mechanism was dominant, an equal mole of pepsin was added to accelerate the bimolecular reaction during activation. The addition of exogenous pepsin did not affect the activation rate of the engineered pepsinogen but accelerated pepsinogen activation through the bimolecular reaction. The above results indicated that the engineered pepsinogen exhibited, primarily, a self-activation mechanism and that bimolecular activation was negligible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143341     DOI: 10.1006/abbi.1997.9925

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  The pepsin residue glycine-76 contributes to active-site loop flexibility and participates in catalysis.

Authors:  M Okoniewska; T Tanaka; R Y Yada
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin.

Authors:  C Richter; T Tanaka; R Y Yada
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

3.  Pro-domain removal in ASP-2 and the cleavage of the amyloid precursor are influenced by pH.

Authors:  Christina Sidera; Chibuu Liu; Brian Austen
Journal:  BMC Biochem       Date:  2002-08-31       Impact factor: 4.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.